<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are a recognised prothrombotic risk factor associated with <z:hpo ids='HP_0011009'>acute</z:hpo> ischaemic infarction </plain></SENT>
<SENT sid="1" pm="."><plain>Most <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> are rare in infants, and in the neonatal period, <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> is related to transplacental passage of maternal immunoglobulin G autoantibodies </plain></SENT>
<SENT sid="2" pm="."><plain>Distinguishing between de novo and acquired <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> has important therapeutic implications and is crucial for determining the prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>We present a case of a neonatal thrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> associated with de novo synthesis of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, a homozygous 1298C/C <z:chebi fb="13" ids="29357,29358">methylene</z:chebi>-<z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase mutation and a double-homozygous plasminogen activator inhibitor 1 polymorphism (PAI-1 844A/A and 675 4G/4G), which may have increased the final thrombotic risk </plain></SENT>
<SENT sid="4" pm="."><plain>Her mother was not positive for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The authors highlight an unequivocal evidence of a de novo case of paediatric <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome and emphasise the need for a thorough investigation in cases of neonatal <z:hpo ids='HP_0001297'>stroke</z:hpo> including molecular <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> study </plain></SENT>
</text></document>